ClinicalTrials.Veeva

Menu

HM vs Fibreglass Cast Immbolization for Supracondylar Fractures

K

KK Women's and Children's Hospital

Status

Completed

Conditions

Pediatric Supracondylar Humeral Fracture

Treatments

Device: Fibreglass Cast
Device: HM Cast

Study type

Interventional

Funder types

Other

Identifiers

NCT05430074
CIRB Ref: 2022/2409

Details and patient eligibility

About

Supracondylar humeral fractures are the most common elbow fractures in children and cast immobilization continues to remain as the recommended treatment for modified Gartland's classification Type I and Type IIa injuries. Apart from plaster of Paris and fibreglass casts, the use of waterproof, tubular hybrid mesh (HM) casts have been gaining traction for cast immobilization. Although the use of HM cast has been reported to have similar clinical outcomes and overall patient satisfaction scores to the fibreglass cast, the results of the recent studies are only limited and generalizable only to paediatric distal radius fractures.

As the application method of HM and fibreglass casts are fundamentally different, it has not been reported if the difference in application duration between the cast materials is significant and its potential implications in outpatient clinic operation.

Hence, through a randomized controlled trial, this study primarily aims to investigate if the clinical outcomes, patient satisfaction and duration of cast application with the HM casts would be comparable with fibreglass casts in children with supracondylar humeral fractures.

Through this study, the investigators hope to evaluate the advantages and disadvantages of the respective casting material which may better aid physicians in deciding a more appropriate cast material for treating paediatric supracondylar humeral fractures with cast immobilization and the implications of casting duration on clinic operations.

Enrollment

79 patients

Sex

All

Ages

Under 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First Presentation of Supracondylar humeral fracture (Type I and IIa modified Gartland's classification)

Exclusion criteria

  • Prior treatment of supracondylar humeral fracture
  • Previous elbow injuries
  • Open fractures
  • Polytrauma
  • Neurovascular injuries

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

79 participants in 2 patient groups

HM Cast
Other group
Treatment:
Device: HM Cast
Fibreglass Cast
Other group
Treatment:
Device: Fibreglass Cast

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems